Skip to main content
. 2020 Jun 26;43(9):zsaa123. doi: 10.1093/sleep/zsaa123

Figure 6.

Figure 6.

Change from baseline for sWASO over 6 months. p values are based on the mixed-effect repeated measures model evaluating the LSM treatment difference between PBO and LEM. LEM5, lemborexant 5 mg; LEM10, lemborexant 10 mg; LSM, least squares mean; PBO, placebo; SE, standard error; sWASO, subjective wake after sleep onset. *p < 0.0001; p < 0.001; p < 0.01; §p < 0.05.